Icon

Teflaro - (400, 600 mg/ vial)

Ceftaroline fosamil Allergan
400, 600 mg/ vial
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
None
Less Than 5
None
Teflaro® is a cephalosporin antibacterial indicated in adult and pediatric patients for the treatment of the following infection caused by designated susceptible bacteria: Acute bacterial skin and skin structure infections (ABSSSI) in adult and pediatric patients, Community-acquired bacterial pneumonia (CABP) in adult and pediatric patients 2 months of age and older
Yes
****** *** ****** *** ****. **** ***** * **** ** *** **** *********. ** ****** **** **** **** ****** ** *** ****. *****, ******** ******* **** **** ****, ***** *** ***** ** ********** *** *******. ********* ** ****** ******** ******, ****** ***** * **** *** ** ******* '*** *** '***. **, ****** ***'* ****** *** ******* ****** *** ****. (*****://***.**********.***.***/**********_****/*********/****/********************.***)
Teflaro Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
****** ******* **** *** **** *** ******* *** *********
****** ******* ******* ******* ******* *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ** *** *, **** ******* ******** ************ ***** *** ****
****** *** \ ** *** *, **** ******* **** ******* *** **** ** *** ****
  1. *** *, **** : ******** ***** * **** ******* ****** *** ****** ** ******* '***, '***, '*** *** '***.
  2. *** **, **** : ******** ******* **** ******, ***** *** ***** ** ********** *** *******.
  3. *** **, **** : ******** ******* **** ******, ***** *** ***** ** ********** *** *******.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.